Liabilities / Assets
80th percentile
Tied with the lowest-debt nonprofits in its peer group.
990PF • Fiscal year 2015 • EIN 81-0756743
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
80th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
80th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
99th percentile
Higher net margin than 99% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
$1
No earlier filing loaded for comparison.
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
$0
No earlier filing loaded for comparison.
Revenue
$1
No earlier filing loaded for comparison.
Expenses
$0
No earlier filing loaded for comparison.
Net Income
$1
No earlier filing loaded for comparison.
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Our mission is to break down barriers to als research to find effective treatments. By uniting academia, the pharma and biotech industry, government, venture capital, related nonprofits, and the als community, we aim to overcome the challenges that have long hindered progress, bringing hope and tangible advancements to those affected by this devastating disease.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990PFSummary only. Only limited summary data is available for this year.